EagleClaw Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$952K Sell
8,590
-1,070
-11% -$119K 0.14% 92
2025
Q1
$1.08M Buy
9,660
+600
+7% +$67.2K 0.17% 92
2024
Q4
$837K Hold
9,060
0.13% 92
2024
Q3
$760K Buy
9,060
+325
+4% +$27.2K 0.13% 94
2024
Q2
$599K Hold
8,735
0.11% 97
2024
Q1
$640K Sell
8,735
-490
-5% -$35.9K 0.12% 98
2023
Q4
$747K Hold
9,225
0.16% 91
2023
Q3
$691K Sell
9,225
-550
-6% -$41.2K 0.16% 90
2023
Q2
$753K Sell
9,775
-300
-3% -$23.1K 0.17% 92
2023
Q1
$836K Sell
10,075
-900
-8% -$74.7K 0.2% 84
2022
Q4
$942K Hold
10,975
0.23% 81
2022
Q3
$677K Buy
10,975
+200
+2% +$12.3K 0.19% 86
2022
Q2
$666K Buy
10,775
+300
+3% +$18.5K 0.18% 84
2022
Q1
$623K Sell
10,475
-3,350
-24% -$199K 0.14% 93
2021
Q4
$1M Sell
13,825
-29,045
-68% -$2.11M 0.22% 81
2021
Q3
$2.99M Buy
42,870
+516
+1% +$36K 0.77% 41
2021
Q2
$2.92M Buy
42,354
+1,092
+3% +$75.2K 0.75% 43
2021
Q1
$2.67M Buy
41,262
+2,149
+5% +$139K 0.77% 41
2020
Q4
$2.27M Sell
39,113
-4,079
-9% -$237K 0.72% 46
2020
Q3
$2.73M Buy
43,192
+170
+0.4% +$10.7K 0.96% 31
2020
Q2
$3.31M Sell
43,022
-1,100
-2% -$84.6K 1.28% 24
2020
Q1
$3.29M Buy
44,122
+370
+0.8% +$27.6K 1.55% 21
2019
Q4
$2.84M Buy
43,752
+3,925
+10% +$255K 1.04% 32
2019
Q3
$2.52M Buy
39,827
+7,025
+21% +$445K 1.03% 30
2019
Q2
$2.22M Buy
32,802
+6,225
+23% +$422K 0.97% 31
2019
Q1
$1.73M Buy
26,577
+275
+1% +$17.9K 0.79% 43
2018
Q4
$1.65M Sell
26,302
-1,353
-5% -$85K 0.87% 39
2018
Q3
$2.14M Buy
27,655
+4,405
+19% +$340K 0.94% 31
2018
Q2
$1.65M Sell
23,250
-75
-0.3% -$5.31K 0.8% 41
2018
Q1
$1.76M Buy
23,325
+900
+4% +$67.8K 0.89% 38
2017
Q4
$1.61M Buy
22,425
+400
+2% +$28.7K 0.81% 49
2017
Q3
$1.78M Buy
22,025
+3,200
+17% +$258K 1% 35
2017
Q2
$1.33M Sell
18,825
-575
-3% -$40.6K 0.78% 51
2017
Q1
$1.32M Sell
19,400
-275
-1% -$18.7K 0.79% 52
2016
Q4
$1.41M Sell
19,675
-950
-5% -$68K 0.89% 42
2016
Q3
$1.64M Buy
20,625
+675
+3% +$53.7K 1.05% 37
2016
Q2
$1.66M Buy
19,950
+3,625
+22% +$302K 1.11% 32
2016
Q1
$1.5M Buy
16,325
+3,825
+31% +$351K 1.02% 36
2015
Q4
$1.26M Buy
12,500
+500
+4% +$50.4K 0.84% 45
2015
Q3
$1.18M Buy
12,000
+1,650
+16% +$162K 0.83% 44
2015
Q2
$1.21M Buy
10,350
+925
+10% +$108K 0.78% 48
2015
Q1
$925K Buy
9,425
+400
+4% +$39.3K 0.6% 55
2014
Q4
$850K Buy
9,025
+550
+6% +$51.8K 0.56% 58
2014
Q3
$901K Buy
8,475
+200
+2% +$21.3K 0.61% 56
2014
Q2
$686K Buy
+8,275
New +$686K 0.47% 65